 
| In ZINC since | Heavy atoms | Benign functionality | 
|---|---|---|
| February 4th, 2009 | 36 | No | 
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL | 
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 1.59 | 8.01 | -56.96 | 4 | 11 | -1 | 161 | 512.568 | 10 | ↓ | 
| Mid Mid (pH 6-8) | 1.59 | 7.85 | -80.64 | 5 | 11 | 0 | 163 | 513.576 | 11 | ↓ | 
| Lo Low (pH 4.5-6) | 1.59 | 9.08 | -73.25 | 5 | 11 | 0 | 163 | 513.576 | 10 | ↓ | 
| Note Type | Comments | Provided By | 
|---|---|---|
| PUBCHEM_PATENT_ID | EP0960882A1; WO1999059992A1 | IBM Patent Data | 
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type | 
|---|---|---|---|---|---|
| ITA2B-1-E | Integrin Alpha-IIb (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2450 | 0.22 | Binding ≤ 10μM | 
| ITB3-1-E | Integrin Beta-3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2450 | 0.22 | Binding ≤ 10μM | 
| Z104292-1-O | Integrin Alpha-V/beta-3 (cluster #1 Of 1), Other | Other | 60 | 0.28 | Binding ≤ 10μM | 
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type | 
|---|---|---|---|---|---|
| Z104292 | Z104292 | Integrin Alpha-V/beta-3 | 41 | 0.29 | Binding ≤ 1μM | 
| ITA2B_HUMAN | P08514 | Integrin Alpha-IIb, Human | 2450 | 0.22 | Binding ≤ 10μM | 
| Z104292 | Z104292 | Integrin Alpha-V/beta-3 | 41 | 0.29 | Binding ≤ 10μM | 
| ITB3_HUMAN | P05106 | Integrin Beta-3, Human | 2450 | 0.22 | Binding ≤ 10μM | 
| Description | Species | 
|---|---|
| ECM proteoglycans | |
| Elastic fibre formation | |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | |
| Integrin alphaIIb beta3 signaling | |
| Integrin cell surface interactions | |
| Molecules associated with elastic fibres | |
| p130Cas linkage to MAPK signaling for integrins | |
| PECAM1 interactions | |
| Platelet degranulation | |
| Signal transduction by L1 | |
| Syndecan interactions | |
| VEGFA-VEGFR2 Pathway |